PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
238.00 - 242.07
140.53 - 242.25
26.77M / 38.44M (Avg.)
25.64 | 9.39
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-8.23%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-3.76%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-4.10%
Negative EBIT growth while BIDU is at 8.43%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-4.10%
Negative operating income growth while BIDU is at 8.43%. Joel Greenblatt would press for urgent turnaround measures.
10.47%
Net income growth at 50-75% of BIDU's 17.61%. Martin Whitman would question fundamental disadvantages in expenses or demand.
11.32%
EPS growth at 50-75% of BIDU's 17.44%. Martin Whitman would suspect a lag in operational efficiency or a higher share count.
11.43%
Diluted EPS growth at 50-75% of BIDU's 17.06%. Martin Whitman would question if share issuance or modest net income gains hamper progress.
-0.90%
Share reduction while BIDU is at 0.32%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-0.96%
Reduced diluted shares while BIDU is at 1.29%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
No Data
No Data available this quarter, please select a different quarter.
-0.44%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
7.50%
Positive FCF growth while BIDU is negative. John Neff would see a strong competitive edge in net cash generation.
416.67%
Similar 10Y revenue/share CAGR to BIDU's 421.70%. Walter Schloss might see both firms benefiting from the same long-term demand.
143.62%
5Y revenue/share CAGR above 1.5x BIDU's 48.38%. David Dodd would look for consistent product or market expansions fueling outperformance.
82.13%
3Y revenue/share CAGR above 1.5x BIDU's 36.56%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
569.23%
10Y OCF/share CAGR above 1.5x BIDU's 167.16%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
119.56%
OCF/share CAGR of 119.56% while BIDU is zero. Bruce Berkowitz would see if modest momentum can translate into a bigger competitive lead.
120.53%
3Y OCF/share CAGR at 50-75% of BIDU's 162.78%. Martin Whitman would suspect weaker recent execution or product competitiveness.
365.21%
Net income/share CAGR above 1.5x BIDU's 185.09% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
74.07%
Positive 5Y CAGR while BIDU is negative. John Neff might view this as a strong mid-term relative advantage.
136.51%
Below 50% of BIDU's 13944.83%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
257.50%
Below 50% of BIDU's 712.38%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
76.38%
5Y equity/share CAGR is in line with BIDU's 84.09%. Walter Schloss would see parallel mid-term profitability and retention policies.
37.61%
3Y equity/share CAGR similar to BIDU's 39.51%. Walter Schloss sees both having parallel profitability or reinvestment over 3 years.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-10.49%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
-13.30%
Inventory is declining while BIDU stands at 817.03%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
1.16%
Asset growth well under 50% of BIDU's 2.56%. Michael Burry sees the competitor as far more aggressive in building resources or capacity.
2.78%
50-75% of BIDU's 3.77%. Martin Whitman suspects weaker earnings or capital allocation vs. the competitor.
-10.72%
We’re deleveraging while BIDU stands at 3.36%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
11.70%
We increase R&D while BIDU cuts. John Neff sees a short-term profit drag but a potential lead in future innovations.
-16.18%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.